• Published On : Sep-2017 |
  • Pages : 224 Pages |
  • Format :

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Market View Point
   3.1. Opportunity Analysis
   3.2. Global Market Drivers
        3.2.1. Macroeconomic Drivers
        3.2.2. Demand-side Drivers
        3.2.3. Supply-side Drivers
   3.3. Global Market Restraints
   3.4. Global Market Trends
   3.5. Epidemiology data of Sickle cell Disease, 2015
   3.6. Epidemiology data of Sickle cell Disease < 5 years, 2015 
   3.7. Product Pipeline Analysis

4. North America Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025
   4.1. Introduction
   4.2. Regional Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
   4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
        4.3.1. U.S.
        4.3.2. Canada
   4.4. Market Size (US$ Mn) and Forecast By Country, 2017–2025
        4.4.1. U.S.
        4.4.2. Canada
   4.5. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
        4.5.1. Hydroxyurea
        4.5.2. Antibiotics
        4.5.3. Pain-relieving Medications
        4.5.4. Others
   4.6. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
        4.6.1. Hydroxyurea
        4.6.2. Antibiotics
        4.6.3. Pain-relieving Medications
        4.6.4. Others
   4.7. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012–2016
        4.7.1. Sickle cell anemia
        4.7.2. Sickle hemoglobin C disease
        4.7.3. Sickle beta thalassemia
        4.7.4. Others
   4.8. Market Size (US$ Mn) and Forecast, By Disease Type, 2017–2025
        4.8.1. Sickle cell anemia
        4.8.2. Sickle hemoglobin C disease
        4.8.3. Sickle beta thalassemia
        4.8.4. Others
   4.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
        4.9.1. Hospital Pharmacies
        4.9.2. Retail Pharmacies
        4.9.3. Online Pharmacies
   4.10.Market Size (US$ Mn) and Forecast, By Distribution Channel, 2017–2025
        4.10.1. Hospital Pharmacies
        4.10.2. Retail Pharmacies
        4.10.3. Online Pharmacies
   4.11.Drivers and Restraints: Impact Analysis
   4.12.Market Attractiveness Analysis
        4.12.1. By Country
        4.12.2. By Drug Type
        4.12.3. By Disease Type
        4.12.4. By Distribution Channel

5. Latin America Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025
   5.1. Introduction
   5.2. Regional Market Dynamics
        5.2.1. Drivers
        5.2.2. Restraints
        5.2.3. Trends
   5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
        5.3.1. Brazil
        5.3.2. Mexico
        5.3.3. Rest of Latin America
   5.4. Market Size (US$ Mn) and Forecast By Country, 2017–2025
        5.4.1. Brazil
        5.4.2. Mexico
        5.4.3. Rest of Latin America
   5.5. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
        5.5.1. Hydroxyurea
        5.5.2. Antibiotics
        5.5.3. Pain-relieving Medications
        5.5.4. Others
   5.6. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
        5.6.1. Hydroxyurea
        5.6.2. Antibiotics
        5.6.3. Pain-relieving Medications
        5.6.4. Others
   5.7. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012–2016
        5.7.1. Sickle cell anemia
        5.7.2. Sickle hemoglobin C disease
        5.7.3. Sickle beta thalassemia
        5.7.4. Others
   5.8. Market Size (US$ Mn) and Forecast, By Disease Type, 2017–2025
        5.8.1. Sickle cell anemia
        5.8.2. Sickle hemoglobin C disease
        5.8.3. Sickle beta thalassemia
        5.8.4. Others
   5.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
        5.9.1. Hospital Pharmacies
        5.9.2. Retail Pharmacies
        5.9.3. Online Pharmacies
   5.10.Market Size (US$ Mn) and Forecast, By Distribution Channel, 2017–2025
        5.10.1. Hospital Pharmacies
        5.10.2. Retail Pharmacies
        5.10.3. Online Pharmacies
   5.11.Drivers and Restraints: Impact Analysis
   5.12.Market Attractiveness Analysis
        5.12.1. By Country
        5.12.2. By Drug Type
        5.12.3. By Disease Type
        5.12.4. By Distribution Channel

6. Europe Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025
   6.1. Introduction
   6.2. Regional Market Dynamics
        6.2.1. Drivers
        6.2.2. Restraints
   6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
        6.3.1. Germany
        6.3.2. France
        6.3.3. U.K.
        6.3.4. Spain
        6.3.5. Italy
        6.3.6. Russia
        6.3.7. Rest of Europe
   6.4. Market Size (US$ Mn) and Forecast By Country, 2017–2025
        6.4.1. Germany
        6.4.2. France
        6.4.3. U.K.
        6.4.4. Spain
        6.4.5. Italy
        6.4.6. Russia
        6.4.7. Rest of Europe
   6.5. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
        6.5.1. Hydroxyurea
        6.5.2. Antibiotics
        6.5.3. Pain-relieving Medications
        6.5.4. Others
   6.6. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
        6.6.1. Hydroxyurea
        6.6.2. Antibiotics
        6.6.3. Pain-relieving Medications
        6.6.4. Others
   6.7. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012–2016
        6.7.1. Sickle cell anemia
        6.7.2. Sickle hemoglobin C disease
        6.7.3. Sickle beta thalassemia
        6.7.4. Others
   6.8. Market Size (US$ Mn) and Forecast, By Disease Type, 2017–2025
        6.8.1. Sickle cell anemia
        6.8.2. Sickle hemoglobin C disease
        6.8.3. Sickle beta thalassemia
        6.8.4. Others
   6.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
        6.9.1. Hospital Pharmacies
        6.9.2. Retail Pharmacies
        6.9.3. Online Pharmacies
   6.10.Market Size (US$ Mn) and Forecast, By Distribution Channel, 2017–2025
        6.10.1. Hospital Pharmacies
        6.10.2. Retail Pharmacies
        6.10.3. Online Pharmacies
   6.11.Drivers and Restraints: Impact Analysis
        6.12.Market Attractiveness Analysis
        6.12.1. By Country
        6.12.2. By Drug Type
        6.12.3. By Disease Type
        6.12.4. By Distribution Channel

7. Asia Pacific Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025
   7.1. Introduction
   7.2. Regional Market Dynamics
        7.2.1. Drivers
        7.2.2. Restraints
   7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
        7.3.1. China
        7.3.2. India
        7.3.3. Japan
        7.3.4. Australia and New Zealand
        7.3.5. ASEAN
        7.3.6. Rest of ASIA PACIFIC
   7.4. Market Size (US$ Mn) and Forecast By Country, 2017–2025
        7.4.1. China
        7.4.2. India
        7.4.3. Japan
        7.4.4. Australia and New Zealand
        7.4.5. ASEAN
        7.4.6. Rest of Asia Pacific
   7.5. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
        7.5.1. Hydroxyurea
        7.5.2. Antibiotics
        7.5.3. Pain-relieving Medications
        7.5.4. Others
   7.6. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
        7.6.1. Hydroxyurea
        7.6.2. Antibiotics
        7.6.3. Pain-relieving Medications
        7.6.4. Others
   7.7. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012–2016
        7.7.1. Sickle cell anemia
        7.7.2. Sickle hemoglobin C disease
        7.7.3. Sickle beta thalassemia
        7.7.4. Others
   7.8. Market Size (US$ Mn) and Forecast, By Disease Type, 2017–2025
        7.8.1. Sickle cell anemia
        7.8.2. Sickle hemoglobin C disease
        7.8.3. Sickle beta thalassemia
        7.8.4. Others
   7.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
        7.9.1. Hospital Pharmacies
        7.9.2. Retail Pharmacies
        7.9.3. Online Pharmacies
   7.10.Market Size (US$ Mn) and Forecast, By Distribution Channel, 2017–2025
        7.10.1. Hospital Pharmacies
        7.10.2. Retail Pharmacies
        7.10.3. Online Pharmacies
   7.11.Drivers and Restraints: Impact Analysis
   7.12.Market Attractiveness Analysis
        7.12.1. By Country
        7.12.2. By Drug Type
        7.12.3. By Disease Type
        7.12.4. By Distribution Channel

8. MEA Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025
   8.1. Introduction
   8.2. Regional Market Dynamics
        8.2.1. Drivers
        8.2.2. Restraints
   8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
        8.3.1. GCC Countries
        8.3.2. South Africa
        8.3.3. Rest of MEA
   8.4. Market Size (US$ Mn) and Forecast By Country, , 2017–2025
        8.4.1. GCC Countries
        8.4.2. South Africa
        8.4.3. Rest of MEA
   8.5. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
        8.5.1. Hydroxyurea
        8.5.2. Antibiotics
        8.5.3. Pain-relieving Medications
        8.5.4. Others
   8.6. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
        8.6.1. Hydroxyurea
        8.6.2. Antibiotics
        8.6.3. Pain-relieving Medications
        8.6.4. Others
   8.7. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012–2016
        8.7.1. Sickle cell anemia
        8.7.2. Sickle hemoglobin C disease
        8.7.3. Sickle beta thalassemia
        8.7.4. Others
   8.8. Market Size (US$ Mn) and Forecast, By Disease Type, 2017–2025
        8.8.1. Sickle cell anemia
        8.8.2. Sickle hemoglobin C disease
        8.8.3. Sickle beta thalassemia
        8.8.4. Others
   8.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
        8.9.1. Hospital Pharmacies
        8.9.2. Retail Pharmacies
        8.9.3. Online Pharmacies
   8.10.Market Size (US$ Mn) and Forecast, By Distribution Channel, 2017–2025
        8.10.1. Hospital Pharmacies
        8.10.2. Retail Pharmacies
        8.10.3. Online Pharmacies
   8.11.Drivers and Restraints: Impact Analysis
   8.12.Market Attractiveness Analysis
        8.12.1. By Country
        8.12.2. By Drug Type
        8.12.3. By Disease Type
        8.12.4. By Distribution Channel

9. Forecast Assumptions

10. Competition Landscape
   10.1.Competition Dashboard
   10.2.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
        10.2.1. AstraZeneca Plc.
        10.2.2. Eli Lilly and Company
        10.2.3. Bristol-Myers Squibb Company
        10.2.4. Novartis AG
        10.2.5. Pfizer Inc.
        10.2.6. Baxter International Inc.
        10.2.7. Emmaus Life Sciences, Inc.
        10.2.8. Bluebird bio, Inc.
        10.2.9. Global Blood Therapeutics Inc.
        10.2.10. Sangamo Therapeutics, Inc.
        10.2.11. Acceleron Pharma, Inc.
        10.2.12. Arena Pharmaceuticals, Inc.
        10.2.13. Alnylam Pharmaceuticals, Inc.

11. Global Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Region
   11.1.Introduction / Key Findings
   11.2.Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
        11.2.1. North America
        11.2.2. Latin America
        11.2.3. Europe
        11.2.4. Asia Pacific
        11.2.5. MEA
   11.3.Market Size (US$ Mn) Forecast By Region, 2017-2025
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. Europe
        11.3.4. Asia Pacific
        11.3.5. MEA
   11.4.Market Attractiveness Analysis By Region

12. Global Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Drug Type
   12.1.Introduction
   12.2.Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
        12.2.1. Hydroxyurea
        12.2.2. Antibiotics
        12.2.3. Pain-relieving Medications
        12.2.4. Others
   12.3.Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
        12.3.1. Hydroxyurea
        12.3.2. Antibiotics
        12.3.3. Pain-relieving Medications
        12.3.4. Others
   12.4.Market Attractiveness Analysis By Drug Type

13. Global Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Disease Type
   13.1.Introduction
   13.2.Historical Market Size (US$ Mn) Analysis By Disease Type, 2012–2016
        13.2.1. Sickle cell anemia
        13.2.2. Sickle hemoglobin C disease
        13.2.3. Sickle beta thalassemia
        13.2.4. Others
   13.3.Market Size (US$ Mn) and Forecast, By Disease Type, 2017–2025
        13.3.1. Sickle cell anemia
        13.3.2. Sickle hemoglobin C disease
        13.3.3. Sickle beta thalassemia
        13.3.4. Others
   13.4.Market Attractiveness Analysis By Disease Type

14. Global Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel
   14.1.Introduction
   14.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
        14.2.1. Hospital Pharmacies
        14.2.2. Retail Pharmacies
        14.2.3. Online pharmacies
   14.3.Market Size (US$ Mn) and Forecast By Distribution Channel, 2017-2025
        14.3.1. Hospital Pharmacies
        14.3.2. Retail Pharmacies
        14.3.3. Online pharmacies
   14.4.Market Attractive Analysis By Distribution Channel

15. Global Market Analysis 2012–2016 and Forecast 2017–2025
   15.1.Market Size and Y-o-Y Growth
   15.2.Absolute $ Opportunity

16. Research Methodolog


List of Tables

Table 1: Epidemiology data of Sickle cell Disease 2015 
Table 2: Epidemiology data of Sickle cell Disease < 5 years 2015
Table 3: Pipeline Products 
Table 4: North America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 5: North America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Type
Table 6: North America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Type
Table 7: Latin America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 8: Latin America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Type
Table 9: Latin America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Type
Table 10: Europe Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 11: Europe Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Type
Table 12: Europe Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Type
Table 13: APAC Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 14: APAC Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Type
Table 15: APAC Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Type
Table 16: MEA Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 17: MEA Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Type
Table 18: MEA Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Type
Table 19: Global Sickle Cell Disease Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region 
Table 20: Global Sickle Cell Disease Treatment Market Size (US$ Mn) 2012–2016 and Forecast, 2017-2025, By Drug Type 
Table 21: Global Sickle Cell Disease Treatment Market Size (US$ Mn) 2012–2016 and Forecast, 2017-2025, By Disease Type
Table 22: Global Sickle Cell Disease Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025, By Distribution Channel


List of Figures

Figure 1: Global Sickle Cell Disease Treatment Market Revenue Share, By Drug Type (2017)
Figure 2: Global Sickle Cell Disease Treatment Market Revenue Share, By Indication (2017)
Figure 3: Global Sickle Cell Disease Treatment Market Revenue Share, By Distribution Channel (2017)
Figure 4: North America Sickle Cell Disease Treatment Market Value Share (%) By Drug Type (2017)
Figure 5: North America Sickle Cell Disease Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 6: North America Sickle Cell Disease Treatment Market Value Share (%) By Disease Indication (2017)
Figure 7: North America Sickle Cell Disease Treatment Market Value Share (%) By Country (2017)
Figure 8: North America Sickle Cell Disease Treatment Market Value (US$ Mn) & Forecast 2017 & 2025
Figure 9: North America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 10: North America Sickle Cell Disease Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 11: North America Hydroxyurea Market Size (US$ Mn) Analysis, 2012–2016
Figure 12: North America Hydroxyurea Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 13: North America Antibiotics Market Size (US$ Mn) Analysis, 2012–2016
Figure 14: North America Antibiotics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 15: North America Pain-relieving Medications Market Size (US$ Mn) Analysis, 2012–2016
Figure 16: North America Pain-relieving Medications Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 17: North America Others Market Size (US$ Mn) Analysis, 2012–2016
Figure 18: North America Others Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 19: North America Sickle cell anemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 20: North America Sickle cell anemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 21: North America Sickle Hemoglobin C Disease Market Size (US$ Mn) Analysis, 2012–2016
Figure 22: North America Sickle Hemoglobin C Disease Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 23: North America Sickle Beta Thalassemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 24: North America Sickle Beta Thalassemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 25: North America Hospital Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 26: North America Hospital Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 27: North America Retail Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 28: North America Retail Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 29: North America Online Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 30: North America Online Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 31: North America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Drug Type
Figure 32: North America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Disease Type
Figure 33: North America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 34: North America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Country
Figure 35: Latin America Sickle Cell Disease Treatment Market Value Share (%) By Drug Type (2017)
Figure 36: Latin America Sickle Cell Disease Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 37: Latin America Sickle Cell Disease Treatment Market Value Share (%) By Disease Indication (2017)
Figure 38: Latin America Sickle Cell Disease Treatment Market Value Share (%) By Country (2017)
Figure 40: Latin America Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 41: Latin America Sickle Cell Disease Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 42: Latin America Hydroxyurea Market Size (US$ Mn) Analysis, 2012–2016
Figure 43: Latin America Hydroxyurea Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 44: Latin America Antibiotics Market Size (US$ Mn) Analysis, 2012–2016
Figure 45: Latin America Antibiotics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 46: Latin America Pain-relieving Medications Market Size (US$ Mn) Analysis, 2012–2016
Figure 47: Latin America Pain-relieving Medications Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 48: Latin America Others Market Size (US$ Mn) Analysis, 2012–2016
Figure 49: Latin America Others Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 50: Latin America Sickle cell anemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 51: Latin America Sickle cell anemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 52: Latin America Sickle Hemoglobin C Disease Market Size (US$ Mn) Analysis, 2012–2016
Figure 53: Latin America Sickle Hemoglobin C Disease Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 54: Latin America Sickle Beta Thalassemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 55: Latin America Sickle Beta Thalassemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 56: Latin America Hospital Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 57: Latin America Hospital Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 58: Latin America Retail Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 59: Latin America Retail Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 60: Latin America Online Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 61: Latin America Online Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 62: Latin America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Drug Type
Figure 63: Latin America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Disease Type
Figure 64: Latin America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 65: Latin America Sickle Cell Disease Treatment Market Attractiveness Analysis, By Country
Figure 66: Europe Sickle Cell Disease Treatment Market Value Share (%) By Drug Type (2017)
Figure 67: Europe Sickle Cell Disease Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 68: Europe Sickle Cell Disease Treatment Market Value Share (%) By Disease Indication (2017)
Figure 69: Europe Sickle Cell Disease Treatment Market Value Share (%) By Country (2017)
Figure 70: Europe Sickle Cell Disease Treatment Market Value (US$ Mn) & Forecast 2017 & 2025
Figure 71: Europe Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 72: Europe Sickle Cell Disease Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 73: Europe Hydroxyurea Market Size (US$ Mn) Analysis, 2012–2016
Figure 74: Europe Hydroxyurea Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 75: Europe Antibiotics Market Size (US$ Mn) Analysis, 2012–2016
Figure 76: Europe Antibiotics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 77: Europe Pain-relieving Medications Market Size (US$ Mn) Analysis, 2012–2016
Figure 78: Europe Pain-relieving Medications Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 79: Europe Others Market Size (US$ Mn) Analysis, 2012–2016
Figure 80: Europe Others Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 81: Europe Sickle cell anemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 82: Europe Sickle cell anemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 83: Europe Sickle Hemoglobin C Disease Market Size (US$ Mn) Analysis, 2012–2016
Figure 84: Europe Sickle Hemoglobin C Disease Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 85: Europe Sickle Beta Thalassemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 86: Europe Sickle Beta Thalassemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 87: Europe Hospital Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 88: Europe Hospital Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 89: Europe Retail Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 90: Europe Retail Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 91: Europe Online Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 92: Europe Online Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 93: Europe Sickle Cell Disease Treatment Market Attractiveness Analysis, By Drug Type
Figure 94: Europe Sickle Cell Disease Treatment Market Attractiveness Analysis, By Disease Type
Figure 95: Europe Sickle Cell Disease Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 96: Europe Sickle Cell Disease Treatment Market Attractiveness Analysis, By Country
Figure 97: APAC Sickle Cell Disease Treatment Market Value Share (%) By Drug Type (2017)
Figure 98: APAC Sickle Cell Disease Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 99: APAC Sickle Cell Disease Treatment Market Value Share (%) By Disease Indication (2017)
Figure 100: APAC Sickle Cell Disease Treatment Market Value Share (%) By Country (2017)
Figure 101: APAC Sickle Cell Disease Treatment Market Value (US$ Mn) & Forecast 2017 & 2025
Figure 102: APAC Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 103: APAC Sickle Cell Disease Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 104: APAC Hydroxyurea Market Size (US$ Mn) Analysis, 2012–2016
Figure 105: APAC Hydroxyurea Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 106: APAC Antibiotics Market Size (US$ Mn) Analysis, 2012–2016
Figure 107: APAC Antibiotics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 108: APAC Pain-relieving Medications Market Size (US$ Mn) Analysis, 2012–2016
Figure 109: APAC Pain-relieving Medications Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 110: APAC Others Market Size (US$ Mn) Analysis, 2012–2016
Figure 111: APAC Others Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 112: APAC Sickle cell anemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 113: APAC Sickle cell anemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 114: APAC Sickle Hemoglobin C Disease Market Size (US$ Mn) Analysis, 2012–2016
Figure 115: APAC Sickle Hemoglobin C Disease Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 116: APAC Sickle Beta Thalassemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 117: APAC Sickle Beta Thalassemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 118: APAC Hospital Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 119: APAC Hospital Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 120: APAC Retail Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 121: APAC Retail Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 122: APAC Online Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 123: APAC Online Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 124: APAC Sickle Cell Disease Treatment Market Attractiveness Analysis, By Drug Type
Figure 125: APAC Sickle Cell Disease Treatment Market Attractiveness Analysis, By Disease Type
Figure 126: APAC Sickle Cell Disease Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 127: APAC Sickle Cell Disease Treatment Market Attractiveness Analysis, By Country
Figure 128: MEA Sickle Cell Disease Treatment Market Value Share (%) By Drug Type (2017)
Figure 129: MEA Sickle Cell Disease Treatment Market Value Share (%) By Distribution Channel (2017)
Figure 130: MEA Sickle Cell Disease Treatment Market Value Share (%) By Disease Indication (2017)
Figure 131: MEA Sickle Cell Disease Treatment Market Value Share (%) By Country (2017)
Figure 132: MEA Sickle Cell Disease Treatment Market Value (US$ Mn) & Forecast 2017 & 2025
Figure 133: MEA Sickle Cell Disease Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 134: MEA Sickle Cell Disease Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 135: MEA Hydroxyurea Market Size (US$ Mn) Analysis, 2012–2016
Figure 136: MEA Hydroxyurea Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 137: MEA Antibiotics Market Size (US$ Mn) Analysis, 2012–2016
Figure 138: MEA Antibiotics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 139: MEA Pain-relieving Medications Market Size (US$ Mn) Analysis, 2012–2016
Figure 140: MEA Pain-relieving Medications Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 141: MEA Others Market Size (US$ Mn) Analysis, 2012–2016
Figure 142: MEA Others Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 143: MEA Sickle cell anemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 144: MEA Sickle cell anemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 145: MEA Sickle Hemoglobin C Disease Market Size (US$ Mn) Analysis, 2012–2016
Figure 146: MEA Sickle Hemoglobin C Disease Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 147: MEA Sickle Beta Thalassemia Market Size (US$ Mn) Analysis, 2012–2016
Figure 148: MEA Sickle Beta Thalassemia Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 149: MEA Hospital Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 150: MEA Hospital Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 151: MEA Retail Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 152: MEA Retail Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 153: MEA Online Pharmacies Market Size (US$ Mn) Analysis, 2012–2016
Figure 154: MEA Online Pharmacies Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 155: MEA Sickle Cell Disease Treatment Market Attractiveness Analysis, By Drug Type
Figure 156: MEA Sickle Cell Disease Treatment Market Attractiveness Analysis, By Disease Type
Figure 157: MEA Sickle Cell Disease Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 158: MEA Sickle Cell Disease Treatment Market Attractiveness Analysis, By Country
Figure 159: Global Sickle Cell Disease Treatment Market Attractiveness Analysis By Region, 2017–2025
Figure 160: Global Sickle Cell Disease Treatment Market Attractiveness Analysis By Drug Type, 2017–2025
Figure 161: Global Sickle Cell Disease Treatment Market Attractiveness Analysis By Disease Type, 2017–2025
Figure 162: Global Sickle Cell Disease Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2025
Figure 163: Global Sickle Cell Disease Treatment Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 164: Global Sickle Cell Disease Treatment Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 165: Global Sickle Cell Disease Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2025